Dr. Reid is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3855 Health Sciences Dr
La Jolla, CA 92093Fax+1 619-543-7277
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1997 - 1999- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1991 - 1994
Stanford University School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1993 - 2024- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2010-2014
- Top Doctors:San Diego Area Castle Connolly, 2013
- America's Top Doctors for Cancer Castle Connolly, 2009-2013
- Join now to see all
Clinical Trials
- Clinical Trial in Patients With Metastatic Colorectal Cancer Start of enrollment: 2004 Apr 01
- A Study of Yttrium-90 Radioactive Resin Microspheres to Treat Colorectal Adenocarcinoma Metastatic to the Liver Start of enrollment: 2010 Jan 01
- Study of Imprime PGG® in Combination With Cetuximab in Subjects With Recurrent or Progressive KRAS Wild Type Colorectal Cancer Start of enrollment: 2011 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 126 citationsWhat's New in SCLC? A ReviewBryan Oronsky, Tony R. Reid, Arnold L. Oronsky, Corey A. Carter
Neoplasia. 2017-10-01 - 20 citationsA 2022 Update on Extensive Stage Small-Cell Lung Cancer (SCLC).Bryan Oronsky, Nacer Abrouk, Scott Caroen, Michelle Lybeck, Xiaoning Guo
Journal of Cancer. 2022-01-01 - 59 citationsElectrolyte disorders with platinum-based chemotherapy: mechanisms, manifestations and management.Bryan Oronsky, Scott Caroen, Arnold L. Oronsky, Vaughn E. Dobalian, Neil Oronsky
Cancer Chemotherapy and Pharmacology. 2017-07-20
Press Mentions
EpicentRx Doses First Subject in Phase III Lung Cancer Trial in ChinaOctober 7th, 2022- • News - Full StoryJuly 12th, 2022
- New Phase 1 Clinical Trial for Pediatric CNS TumorsFebruary 24th, 2022
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
